Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis
Author:
Affiliation:
1. Department of Clinical Research Delhi Pharmaceutical Sciences and Research University (DPSRU) New Delhi India
2. Department of Pharmacology Delhi Pharmaceutical Sciences and Research University (DPSRU) New Delhi India
Publisher
Hindawi Limited
Subject
Neurology (clinical),Neurology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ane.13690
Reference21 articles.
1. Electronic Medicines Compendium.Summary of product characteristics for clobazam accord 10mg tablets. Accessed December 19 2021.https://www.medicines.org.uk/emc/product/5029/smpc#gref
2. Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
3. Macroglossia Associated With Clobazam Administration: A Case Report and Literature Review
4. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System
5. Antiepileptic combination therapy with Stevens‐Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of Signal of Clindamycin Associated Renal Failure Acute: A Disproportionality Analysis;Current Drug Safety;2024-02
2. The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data;International Journal of Cardiology;2024-02
3. Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology;Expert Opinion on Drug Safety;2023-11
4. A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?;Frontiers in Pharmacology;2023-10-26
5. Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports;Expert Opinion on Drug Safety;2023-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3